Compositions of muramyl peptides inhibiting the replication...

Details Compositions of muramyl peptides inhibiting the replication... Compositions of muramyl peptides inhibiting the replication...

A - Human Necessities

61

K

A61K 38/14 (2006.01) A61K 38/19 (2006.01) A61K 38/21 (2006.01)

Patent

CA 2200993

The use of non-toxic muramyl peptides, particularly Murabutide and Murametide, to prepare drugs for inhibiting HIV replication in human is disclosed. Said muramyl peptides are capable of up to 100 % inhibition of retroviral replication in primary host monocyte cultures.

Utilisation de peptides muramyliques, notamment de Murabutide et de Muramétide, pour l'obtention de médicaments empêchant la réplication du VIH chez l'homme. Les peptides muramyliques peuvent permettre d'obtenir jusqu'à 100 % d'inhibition de la réplication rétrovirale dans des cultures monocytaires d'hôtes primaires

Affiliated with

Also associated with

Rating

Compositions of muramyl peptides inhibiting the replication... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions of muramyl peptides inhibiting the replication..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions of muramyl peptides inhibiting the replication... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1356111